Department of Traumatic Orthopedics, Yuncheng Central Hospital, Shanxi Medical University, No. 3690, Hedong East Street, Yanhu District, Yuncheng City, 044000, Shanxi Province, China.
J Orthop Surg Res. 2023 Aug 20;18(1):607. doi: 10.1186/s13018-023-04103-x.
Internal fixation with cephalomedullary nails has been widely used in the treatment of intertrochanteric femoral fractures (IFF). Yet, the difference in efficacy and safety between the commonly used integrated dual-screw cephalomedullary nail (InterTAN) and single-screw cephalomedullary nail remains inconclusive. Thus we performed the present systematic review and meta-analysis.
Randomized controlled trials (RCTs) or observational studies comparing InterTAN with proximal femoral nail anti-rotation (PFNA), the Asian PFNA (PFNA-II), or the Gamma3 nail in treating IFF were searched on PubMed, EMBASE, Web of Science and Cochrane Library from inception to April 30, 2023. The differences in perioperative parameters and clinical and radiological outcomes were evaluated by mean difference (MD) with 95% confidence interval (95%CI). The risks of various complications and mortality were assessed by risk ratio (RR) with 95%CI.
Twenty-three studies comprising 3566 patients were included. Compared with single-screw cephalomedullary nails (PFNA/PFNA-II, Gamma3), InterTAN conferred significantly reduced risk of implant failures (RR = 0.37, 95%CI 0.26 to 0.51, P < 0.001), hip and thigh pain (RR = 0.70, 95%CI 0.55 to 0.90, P = 0.006) and all-cause revision/reoperation (RR = 0.38, 95%CI 0.26 to 0.57, P < 0.001). Moreover, patients treated with InterTAN had significantly higher 1-year Harris Hip Score (MD = 0.82, 95%CI 0.20-1.44, P = 0.010) and shorter time to union/healing (MD = - 0.66 days, 95%CI - 1.16 to - 0.16, P = 0.009). Femoral neck shortening, time to full bearing, and incidences of non-union, infection, deep venous thrombosis, and mortality were comparable between both groups.
The integrated dual-screw InterTAN construct has superior performance in reducing risks of complications and improving clinical and functional outcomes in the treatment of IFF. More well-designed, high-quality RCTs are warranted to confirm these findings.
带髓内钉的内固定已广泛应用于股骨转子间骨折(IFF)的治疗。然而,常用的一体化双螺钉髓内钉(InterTAN)与单螺钉髓内钉(PFNA、PFNA-II 或 Gamma3 钉)在疗效和安全性方面的差异仍不确定。因此,我们进行了这项系统评价和荟萃分析。
我们在 PubMed、EMBASE、Web of Science 和 Cochrane Library 上检索了从成立到 2023 年 4 月 30 日比较 InterTAN 与近端股骨钉抗旋转(PFNA)、亚洲股骨近端钉-II(PFNA-II)或 Gamma3 钉治疗 IFF 的随机对照试验(RCT)或观察性研究。使用均数差(MD)和 95%置信区间(95%CI)评估围手术期参数和临床及影像学结果的差异。使用风险比(RR)和 95%CI 评估各种并发症和死亡率的风险。
纳入 23 项研究,共 3566 例患者。与单螺钉髓内钉(PFNA/PFNA-II、Gamma3)相比,InterTAN 显著降低了内固定失败(RR=0.37,95%CI 0.26-0.51,P<0.001)、髋部和大腿疼痛(RR=0.70,95%CI 0.55-0.90,P=0.006)和全因翻修/再手术(RR=0.38,95%CI 0.26-0.57,P<0.001)的风险。此外,接受 InterTAN 治疗的患者在 1 年时的 Harris 髋关节评分(MD=0.82,95%CI 0.20-1.44,P=0.010)更高,愈合时间(MD=-0.66 天,95%CI-1.16 至-0.16,P=0.009)更短。两组股骨颈缩短、完全负重时间、不愈合、感染、深静脉血栓形成和死亡率无差异。
一体化双螺钉 InterTAN 结构在降低并发症风险和改善 IFF 治疗的临床和功能结果方面具有更好的性能。需要更多设计良好、高质量的 RCT 来证实这些发现。